Deepak Chemtex profit falls 32% as revenue shrinks across the board
Consolidated net profit dropped to ₹8.47 crore from ₹12.51 crore a year ago, with standalone revenue contracting 21% to ₹53.50 crore.
What's new
- Consolidated net profit fell 32% to ₹8.47 crore in FY26 from ₹12.51 crore the year before.
- Consolidative revenue shrank 15% to ₹67.64 crore; standalone revenue dropped 21% to ₹53.50 crore.
- Standalone net profit declined 34% to ₹6.59 crore, with EPS falling to ₹5.97 from ₹9.27.
Why this matters
For a nano-cap chemical company, a 32% profit decline on top of a 15% revenue drop is not a blip. It points to either demand weakness or pricing pressure the company couldn't offset with cost control. The standalone numbers look even worse, which means the consolidated entity is propped up by subsidiary performance.
What we're watching
- Whether the revenue decline accelerates or stabilises in the first half of FY27.
- Management commentary on demand drivers and any planned cost restructuring.
- How standalone versus consolidated performance diverges in coming quarters.
The full read
Deepak Chemtex's FY26 results are a clear earnings warning. Consolidated net profit fell 32% to ₹8.47 crore from ₹12.51 crore the year before, with revenue shrinking 15% to ₹67.64 crore. The standalone business looks worse. Revenue dropped 21% to ₹53.50 crore, profit fell 34% to ₹6.59 crore, and EPS sank to ₹5.97 from ₹9.27. For a nano-cap company, the magnitude of this contraction is material. The gap between standalone and consolidated performance is telling: the consolidated entity is being propped up by a subsidiary, while the core standalone operation is shrinking faster. This is not a quarter of noise. A full-year revenue decline of this size signals either structural demand weakness or pricing pressure that the company hasn't been able to manage. The next test is whether management offers any guidance on the demand outlook or cost actions in the coming concall.
Questions answered
- How bad was the earnings decline for Deepak Chemtex in FY26?
- Consolidated net profit fell 32% to ₹8.47 crore from ₹12.51 crore in the prior year. Standalone profit did worse, declining 34% to ₹6.59 crore.
- What drove the profit decline?
- Revenue contracted across both consolidated (down 15% to ₹67.64 crore) and standalone (down 21% to ₹53.50 crore) segments, pointing to weaker demand or pricing pressure in the chemical business.
- How did EPS change?
- Standalone EPS fell to ₹5.97 from ₹9.27 a year ago, a 35% drop that mirrors the bottom-line contraction.
- Is the standalone business weaker than the consolidated entity?
- Yes. Standalone revenue fell 21% versus 15% for consolidated, and standalone profit fell 34% versus 32% for consolidated, meaning the consolidated entity includes a stronger subsidiary component.